文献速递消化道肿瘤与早癌

肿瘤相关巨噬细胞来源的CXCL8通过自主表达PD-L1决定胃癌免疫逃逸

Tumour-associated macrophages-derived CXCL8 determines immune evasion through autonomous PD-L1 expression in gastric cancer.
PubMed 文献 · Gut · 2019-01-19

研究分析76例胃癌新鲜肿瘤组织中CXCL8主要来源及免疫细胞表型,并对420例根治性切除患者行免疫组化分析。发现CXCL8主要由巨噬细胞分泌,CSF-2促进其分泌;高CXCL8与CD8+ T细胞浸润减少及Ki67+ CD8+ T细胞比例降低相关,且通过诱导巨噬细胞PD-L1抑制CD8+ T细胞功能。CXCR2抑制剂reparixin减少PD-L1+巨噬细胞并促进抗肿瘤免疫。

要点

  • 胃癌组织中CXCL8主要由巨噬细胞分泌,CSF-2促进巨噬细胞来源CXCL8分泌。
  • 高CXCL8与CD8+ T细胞浸润减少及Ki67+ CD8+ T细胞比例降低相关。
  • CXCL8通过诱导巨噬细胞PD-L1抑制CD8+ T细胞功能,CXCR2抑制剂reparixin减少PD-L1+巨噬细胞并促进抗肿瘤免疫。

核心结论

  • CXCL8主要由巨噬细胞分泌,通过诱导PD-L1+巨噬细胞在胃癌中促成免疫抑制微环境。
  • CXCL8抑制剂可能驱动抗肿瘤反应,为胃癌患者提供潜在治疗效应。

研究设计与样本

  • 研究对76例胃癌患者新鲜肿瘤组织行流式细胞术分析CXCL8主要来源及免疫细胞表型。
  • 实时PCR分析胃癌组织CXCL8 mRNA水平。
  • 免疫组化分析纳入420例接受根治性切除术的胃癌患者。
  • 体外培养新鲜肿瘤组织以评估阻断CXCL8通路的潜在治疗效应。

主要发现

  • CXCL8水平升高提示胃癌患者临床结局差和肿瘤进展。
  • 胃癌组织中CXCL8主要由巨噬细胞分泌,集落刺激因子2(CSF-2)促进巨噬细胞来源CXCL8分泌。
  • 高CXCL8水平与CD8+ T细胞浸润减少及Ki67+ CD8+ T细胞比例降低相关。
  • CXCL8通过诱导巨噬细胞PD-L1表达抑制CD8+ T细胞功能。
  • 小分子CXCR2抑制剂reparixin减少程序性死亡配体1(PD-L1+)巨噬细胞并促进抗肿瘤免疫。

临床怎么用

  • 原文结论指出CXCL8抑制剂可能驱动抗肿瘤反应,为胃癌患者提供潜在治疗效应。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Our previous studies have identified CXCL8 as the crucial chemokine responsible for gastric cancer metastasis mediated by loss of RACK1. However, the regulatory effect of CXCL8 on immune surveillance in gastric cancer remains obscure. DESIGN: Flow cytometry analyses were performed to examine major source of CXCL8 and phenotypes of immune cells in fresh tumour tissues from 76 patients with gastric cancer. Real-time PCR was performed to analyse CXCL8 mRNA level in gastric cancer tissues. For immunohistochemical analyses, a total of 420 patients with gastric cancer undergoing curative resection were enrolled. In vitro culture of fresh tumour tissue was performed to evaluate the potential therapeutic effect of blocking CXCL8 pathway in gastric cancer. RESULTS: Increased level of CXCL8 indicates poor clinical outcome and tumour progression in patients with gastric cancer. In gastric cancer tissues, CXCL8 is predominantly secreted by macrophages and colony stimulating factor 2 (CSF-2) facilitates macrophage-derived CXCL8 secretion. High level of CXCL8 is associated with decreased CD8+ T cells infiltration and Ki67+ CD8+ T cells proportion. Moreover, CXCL8 also inhibits CD8+ T cells function by inducing the expression of PD-L1 on macrophages. Finally, we show that a small-molecule CXCR2 inhibitor, reparixin, drives the decreased programmed death-ligand 1 (PD-L1+) macrophages and promotes antitumour immunity. Accordingly, high levels of CXCL8+ macrophages are positively correlated with poor prognosis in patients with gastric cancer. CONCLUSIONS: CXCL8 is predominantly secreted by macrophages and contributes to the immunosuppressive microenvironment by inducing PD-L1+ macrophages in gastric cancer. CXCL8 inhibitors may drive antitumour response, providing potential therapeutic effects for patients with gastric cancer.

来源:Gut,查看原文。版权归原作者所有。

引用

  1. Lin C, He H, Liu H, et al. Tumour-associated macrophages-derived CXCL8 determines immune evasion through autonomous PD-L1 expression in gastric cancer. Gut. 2019. PMID: 30661053. doi:10.1136/gutjnl-2018-316324

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。